In summary, our results suggest that CEBPB facilitates the progression of UCCRC by activating the NF-κB/STAT3 signaling cascade, thereby contributing to a better understanding of the mechanisms underlying the progression from colitis to colon cancer. Here, NFKB1 is linked to malignant colon neoplasm.